Jon Scott Jacobsen
Corporate Officer/Principal en ACLARIS THERAPEUTICS, INC. .
Perfil
Jon Scott Jacobsen is currently working as Chemistry Director at Aclaris Life Sciences, Inc. and as Senior Vice President-Chemistry at Aclaris Therapeutics, Inc. He previously worked as Director-Chemistry Department & Senior Scientist at Pfizer Inc. He completed his undergraduate degree from Harvey Mudd College and his doctorate degree from the University of California, Irvine.
Cargos activos de Jon Scott Jacobsen
| Empresas | Cargo | Inicio |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Jon Scott Jacobsen.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Formación de Jon Scott Jacobsen.
| Harvey Mudd College | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Bolsa de valores
- Insiders
- Jon Scott Jacobsen
